PharmaShots | Incisive News in 3 Shots

Subscribe Now

atoltivimab

Regeneron's Inmazeb (atoltivimab- maftivimab- and odesivimab) Receives the US FDA's Approval as the First Treatment for Ebola

Regeneron's Inmazeb (atoltivimab- maftivimab- and odesivimab) Receives the US FDA's Approval as the First Treatment for Ebola

October 15, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us